Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1.000 | 0.040 | 2 | 197402108 | missense variant | T/A;G | snv |
|
Neoplasms | 0.700 | 1.000 | 1 | 2013 | 2013 | ||||||||
|
1.000 | 0.040 | 2 | 197402109 | missense variant | T/A;C;G | snv |
|
Neoplasms | 0.700 | 1.000 | 1 | 2013 | 2013 | ||||||||
|
0.851 | 0.240 | 2 | 197402759 | missense variant | C/T | snv |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
0.851 | 0.240 | 2 | 197402759 | missense variant | C/T | snv |
|
Neoplasms | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
0.851 | 0.240 | 2 | 197402759 | missense variant | C/T | snv |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
0.851 | 0.240 | 2 | 197402759 | missense variant | C/T | snv |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
2 | 197398422 | intron variant | T/C | snv | 0.20 | 0.18 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | |||||||||
|
1.000 | 0.040 | 2 | 197402636 | missense variant | T/A;C;G | snv | 2.0E-05; 1.2E-05 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2013 | 2013 | |||||||
|
1.000 | 0.040 | 2 | 197402635 | missense variant | C/A;G | snv | 2.4E-05; 4.0E-05 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.732 | 0.280 | 2 | 197402110 | stop gained | T/A;C;G | snv | 9.0E-05 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.851 | 0.200 | 2 | 197402637 | missense variant | T/C;G | snv |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
0.851 | 0.200 | 2 | 197402637 | missense variant | T/C;G | snv |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
0.851 | 0.200 | 2 | 197402637 | missense variant | T/C;G | snv |
|
Neoplasms | 0.700 | 1.000 | 1 | 2013 | 2013 | ||||||||
|
0.851 | 0.200 | 2 | 197402637 | missense variant | T/C;G | snv |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
0.851 | 0.200 | 2 | 197402637 | missense variant | T/C;G | snv |
|
Digestive System Diseases; Neoplasms | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
0.925 | 0.200 | 2 | 197401887 | missense variant | C/T | snv | 7.0E-06 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.925 | 0.200 | 2 | 197401887 | missense variant | C/T | snv | 7.0E-06 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.851 | 0.240 | 2 | 197402760 | missense variant | G/A;C | snv | 4.0E-06 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.851 | 0.240 | 2 | 197402760 | missense variant | G/A;C | snv | 4.0E-06 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.851 | 0.240 | 2 | 197402760 | missense variant | G/A;C | snv | 4.0E-06 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.851 | 0.240 | 2 | 197402760 | missense variant | G/A;C | snv | 4.0E-06 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
1.000 | 0.040 | 2 | 197428967 | intron variant | T/A;C | snv |
|
Behavior and Behavior Mechanisms | 0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
1.000 | 0.040 | 2 | 197428967 | intron variant | T/A;C | snv |
|
Mental Disorders | 0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
0.732 | 0.280 | 2 | 197402110 | stop gained | T/A;C;G | snv | 9.0E-05 |
|
Hemic and Lymphatic Diseases | 0.030 | 1.000 | 3 | 2016 | 2017 | |||||||
|
0.732 | 0.280 | 2 | 197402110 | stop gained | T/A;C;G | snv | 9.0E-05 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 |